Journey Medical (DERM) Accounts Payables (2020 - 2025)
Journey Medical (DERM) has disclosed Accounts Payables for 6 consecutive years, with $11.6 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Accounts Payables fell 24.66% year-over-year to $11.6 million, compared with a TTM value of $11.6 million through Sep 2025, down 24.66%, and an annual FY2024 reading of $16.0 million, down 11.57% over the prior year.
- Accounts Payables was $11.6 million for Q3 2025 at Journey Medical, down from $12.8 million in the prior quarter.
- Across five years, Accounts Payables topped out at $36.6 million in Q4 2022 and bottomed at $370000.0 in Q1 2023.
- Average Accounts Payables over 5 years is $19.8 million, with a median of $16.0 million recorded in 2024.
- The sharpest move saw Accounts Payables soared 5605.15% in 2022, then plummeted 98.63% in 2023.
- Year by year, Accounts Payables stood at $641000.0 in 2021, then skyrocketed by 5605.15% to $36.6 million in 2022, then tumbled by 50.37% to $18.1 million in 2023, then dropped by 11.57% to $16.0 million in 2024, then decreased by 27.99% to $11.6 million in 2025.
- Business Quant data shows Accounts Payables for DERM at $11.6 million in Q3 2025, $12.8 million in Q2 2025, and $14.4 million in Q1 2025.